Bulk Orders 20+ vials
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Growth Hormone & Growth Factor Research
Available in Tesamorelin 8MG / Ipamorelin 2MG (10MG total) and Tesamorelin 13MG / Ipamorelin 3MG (16MG total) per vial. Select the required blend option. Its format centers on the GH axis. Labs study it in models of GHRH pathway activity and growth hormone secretagogue signals.
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkVerified test results
Each batch is analyzed by an independent third-party laboratory before release. The lots below were tested by Chromate and ILS Laboratories. Below is the report for lot TI05, summarized from the certificate the lab published.
Every lot we have published for this compound, grouped by the lab that tested it, newest first. Open any certificate below, exactly as the lab released it.
Side by side
Technical specifications
Peer-reviewed literature
Published research on each compound in this formulation, linked to its PubMed entry. Provided for educational reference only - not product claims.
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Lyophilized research material
A two-peptide blend that combines GHRH-receptor biology with a separate GH-secretagogue pathway.
The current catalog offers tesamorelin/ipamorelin ratios of 8 mg/2 mg and 13 mg/3 mg. Each number belongs to a different ingredient; the choices are not the same blend amount.
Tesamorelin physiological studies and ipamorelin cell/animal pharmacology support the separate component rationales. These sources do not test this combined DA formulation.
Published findings describe the materials and conditions in the cited studies. Receptor or cell-pathway evidence does not establish safety or efficacy of this finished research product. Match the supplied identity and format to the current label and batch documentation.
This research blend is available as 8MG Tesamorelin + 2MG Ipamorelin (10MG total) or 13MG Tesamorelin + 3MG Ipamorelin (16MG total) per vial. Select the required formulation. The TI05 COA applies to the 8MG/2MG option. Its format centers on the GH axis. Labs study it in models of GHRH pathway activity and growth hormone secretagogue signals. Other areas include pituitary axis research and IGF-1 pathway biology. Work also covers metabolic regulation and endocrine signals.
This Disguised Alpha blend is for researchers who want a fuller GH-pathway format in one vial. Each batch goes through our internal QA review. Third-party lab testing backs that review. Our in-house team fills each order directly.
Combines both compounds for GHRH and secretagogue pathway research. The two model types complement each other.
Tesamorelin & Ipamorelin research guide
Primary research relevant to the named compound or clearly identified component is linked below. Experimental results depend on identity, model and formulation.
Described a pentapeptide secretagogue using receptor and hormone-release experiments. It does not validate the composition or combined effects of a blend.
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
The listed milligrams refer to material per vial, not concentration or administration instructions. A prepared solution has its own concentration and stability requirements. Verify the exact selected option and shipping lot.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
The references describe the materials and conditions used by their authors. They do not establish that this commercial formulation was tested. For blends, evidence on an individual component does not validate the finished mixture or establish synergy.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy